Hormone therapies put transgender women at a greater risk of heart related disorders, says study

Heart related disorders are more common among transgender women as they are at a higher risk due to the hormone therapies they undergo, reveals a recent study.

By: Editorial Team | | Published: August 3, 2018 2:56 pm

Transgender individuals, especially women are at a greater risk for heart disease, found a recent study conducted by George Washington University. The experts are blaming masculinisation or feminisation procedures that transgenders undergo to be the risk factors of developing several heart related disorders like myocardial infarction, stroke and venous thromboembolism. These procedures also affect their blood pressure and lipid concentration. The study, published in the Reviews in Endocrine and Metabolic Disorders journal, has revealed that transgender women may develop cardiovascular issues due to the hormone therapies they take. In fact, the estrogen therapy increases the possibility of blood clots or deep venous thrombosis among transgender women. Also Read - World Stroke Day 2019: Coping after a stroke

According to a recent report by ANI, Michael S Irwig, one of the researchers from George Washington University, said: “In clinical studies that followed transgender patients, rates for myocardial infarction were consistently higher in transgender women on estrogen therapy than in transgender men on testosterone.” Also Read - Women with premature ovarian insufficiency face poor sleep and fatigue

“The relationship between endogenous sex hormones and heart disease is complex. In cisgender women, estrogen may have a protective effect,” he added. Also Read - People with HIV at higher risk of heart failure

According to the researchers, more studies are required on the harmful impacts of hormone therapy on the senior transgenders and on estrogen therapies which are most secure for them.

Image Source: Shutterstock

Published : August 3, 2018 2:56 pm

Read Disclaimer

Coming soon: DNA encoded technology based new therapies to fight tuberculosis and malaria

Blocking digestive hormone associated with obesity may prevent pancreatic cancer

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

Coming soon: DNA encoded technology based new therapies to fight tuberculosis and malaria

Blocking digestive hormone associated with obesity may prevent pancreatic cancer

This new test can diagnose COVID-19 in just 20 minutes

COVID-19: Know how to check if you have the right face mask

COVID-19 mental health fallout: Women more stressed than men during the lockdown

COVID-19 Live Updates: Cases in India surge to 24,61,190 as death toll reaches 48,040

About The health Site

Useful Links